Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MHRA approves Venclyxto for newly diagnosed AML

pharmatimesJune 16, 2021

Tag: M14-358 , AML , Venclyxto , Roche , AbbVie

PharmaSources Customer Service